...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers
【24h】

Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers

机译:探索中溶和中溶载体中非晶态固体分散体释放药物的机理

获取原文
获取原文并翻译 | 示例

摘要

The objective of the current study is to mechanistically differentiate the dissolution and supersaturation behaviors of amorphous drugs from amorphous solid dispersions (ASDs) based on medium-soluble versus medium-insoluble carriers under nonsink dissolution conditions through a direct head-to-head comparison. ASDs of indomethacin (IND) were prepared in several polymers which exhibit different solubility behaviors in acidic (pH 1.2) and basic (pH 7.4) dissolution media. The selected polymers range from water-soluble (e.g., PVP and Soluplus) andwater-insoluble (e.g., ethylcellulose and Eudragit RL PO) to those only soluble in an acidic or basic dissolution medium (e.g., Eudragit E100, Eudragit L100, and HPMCAS). At 20 wt.% drug loading, DSC and powder XRD analysis confirmed that the majority of incorporated IND was present in an amorphous state. Our nonsink dissolution results confirm that whether the carrier matrix is medium soluble determines the release mechanism of amorphous drugs from ASD systems which has a direct impact on the rate of supersaturation generation, thus in turn affecting the evolution of supersaturation in amorphous systems. For example, under nonsink dissolution conditions, the release of amorphous IND from medium-soluble carriers is governed by a dissolution-controlled mechanism-leading to an initial surge of supersaturation followed by a sharp decline in drug concentration due to rapid nucleation and crystallization. In contrast, the dissolution of INDASD from medium-insoluble carriers is more gradual as drug release is regulated by a diffusion-controlled mechanism by which drug supersaturation is built up gradually and sustained over an extended period of time without any apparent decline. Since several tested carrier polymers can be switched from soluble to insoluble by simply changing the pH of the dissolution medium, the results obtained here provide unequivocal evidence of the proposed transition of kinetic solubility profiles from the same ASD system induced by changes in the drug release mechanism in dissolution medium of a different pH. (C) 2015 Elsevier B.V. All rights reserved.
机译:当前研究的目的是通过直接的头对头比较,在非吸收剂溶解条件下,基于中溶与中不溶性载体,从无定形固体分散体(ASD)机理上区分无定形药物与无定形固体分散体(ASD)的溶解和过饱和行为。在几种聚合物中制备了吲哚美辛(IND)的ASD,这些聚合物在酸性(pH 1.2)和碱性(pH 7.4)溶解介质中表现出不同的溶解行为。选择的聚合物包括水溶性(例如PVP和Soluplus)和非水溶性(例如乙基纤维素和Eudragit RL PO)到仅可溶于酸性或碱性溶解介质的聚合物(例如Eudragit E100,Eudragit L100和HPMCAS) 。在载药量为20 wt%时,DSC和粉末XRD分析证实掺入的IND大部分以非晶态存在。我们的非沉溶性溶解结果证实,载体基质是否为中等可溶性决定了ASD系统中无定形药物的释放机理,这直接影响过饱和生成速率,进而影响无定形系统中过饱和的演变。例如,在非沉陷溶解条件下,无定形IND从中溶性载体中的释放受溶解控制机制的控制,这导致最初的过饱和激增,随后由于快速成核和结晶而使药物浓度急剧下降。相比之下,INDASD从中等不溶性载体中的溶解更为缓慢,因为药物的释放受扩散控制机制的控制,通过扩散控制机制,药物过饱和逐渐建立并持续较长时间,而没有任何明显的下降。由于可以通过简单地改变溶解介质的pH值将几种经过测试的载体聚合物从可溶性转变为不溶性,因此这里获得的结果明确表明了由药物释放机制的变化引起的同一ASD系统动力学溶解度曲线的拟议转变在不同pH的溶解介质中。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号